Crextil-CV Tablet
Composition: Cefpodoxime Proxetil 200 MG + Clavulanic Acid 125 MG
Packing: 10x1x10 Alu-Alu
Segment: Antibiotic
MRP: ₹3750
Description
Cefpodoxime 200mg + Clavulanic Acid 125mg Tablets | PCD Pharma Franchise
Product Description:
[Creogenic Pharma] offers Cefpodoxime Proxetil 200mg + Clavulanic Acid 125mg Tablets, a potent combination antibiotic for resistant bacterial infections. Manufactured in a WHO-GMP certified facility, this formulation ensures maximum efficacy and safety for patients.
Composition:
- Cefpodoxime Proxetil 200mg
- Clavulanic Acid 125mg
Key Features & Benefits:
- Broad-spectrum activity against gram-positive and gram-negative bacteria
- Clavulanic acid inhibits beta-lactamase, enhancing antibiotic effectiveness
- Effective in respiratory tract, urinary tract, skin, and soft tissue infections
- WHO-GMP compliant manufacturing for global quality standards
Indications:
- Community-acquired pneumonia & bronchitis
- Urinary tract infections (UTI)
- ENT infections like sinusitis, otitis media, tonsillitis
- Skin and soft tissue infections
PCD Pharma Franchise Opportunity:
Partner with us to market Cefpodoxime + Clavulanic Acid Tablets under the PCD pharma franchise model. Get monopoly rights, competitive pricing, and full promotional support to grow your antibiotic portfolio.
